Neurocrine’s Ingrezza Adds Huntington’s Indication, May Have Competitive Edge

Extended-Release Rival Also Approved In 2023

 
• By Mandy Jackson
  
Leadership concept, One leader red sphere leads other boxes
Ingrezza sales already outpace Austedo • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip